Simultaneous mRNA COVID-19 and IIV4 Vaccination Study

Clinical trial NCT05028361 · COMPLETED

Trial details

NCT number: NCT05028361
Sponsor: Duke University
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Quality of Life Injection Site Reaction Adverse Drug Event Systemic Reaction

Start date: 2021-10-04
Primary completion: 2023-03-03
Enrollment: 348

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.